AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-4159824_ITM" title="Facts and information about New antivomiting medicine. (Products).">New antivomiting medicine. (Products).</a>

Close Set up an RSS feed that alerts you when new articles from OB GYN News are available.

Frequently asked questions about RSS feeds

New antivomiting medicine. (Products).

OB GYN News

| July 01, 2003 | COPYRIGHT 2003 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Emend (aprepitant) is approved for use in combination with other antivomiting medicines to help prevent the acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. The drug, which is the first in a new class of medicines, ...

Related articles from newspapers, magazines, journals, and more

For more facts and information, see all results